3PBIOVIAN Revenue and Competitors

Berlin, Germany

Location

N/A

Total Funding

Pharma

Industry

Estimated Revenue & Valuation

  • 3PBIOVIAN's estimated annual revenue is currently $51.7M per year.(i)
  • 3PBIOVIAN's estimated revenue per employee is $201,000

Employee Data

  • 3PBIOVIAN has 257 Employees.(i)
  • 3PBIOVIAN grew their employee count by 527% last year.

3PBIOVIAN's People

NameTitleEmail/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$17.7M887%N/AN/A
#2
$89.4M4459%N/AN/A
#3
$32.4M16125%N/AN/A
#4
$44.4M2217%N/AN/A
#5
$120.2M42717%$446.2MN/A
#6
$54.3M27010%N/AN/A
#7
$49.6M24752%N/AN/A
#8
$21.9M109-1%N/AN/A
#9
$16.5M824%N/AN/A
#10
$26.7M13325%N/AN/A
Add Company

What Is 3PBIOVIAN?

3PBIOVIAN service offering includes microbial and mammalian protein expression platforms, viral vector production for adenoviruses and adeno-associated viruses, cell therapy, and plasmid DNA production, with the provision for fill and finish services for recombinant proteins and viral vectors. Leveraging a combined track record of 40 years in process development and analytical methods development, complemented by the experience in process scale-up, GMP manufacturing, and commercial supply, 3PBIOVIAN is equipped to offer comprehensive manufacturing services at all stages, encompassing Drug Substance and Drug Product. Manufacturing sites in Pamplona-Noáin, Spain, and Turku, Finland seamlessly support the diverse needs of clients, covering pre-clinical and clinical supply to full-scale commercial manufacturing.

keywords:N/A

N/A

Total Funding

257

Number of Employees

$51.7M

Revenue (est)

527%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$41M2575%N/A
#2
$42.4M25722%N/A
#3
N/A25821%N/A
#4
$39.9M259-11%N/A
#5
$40M260-8%$25M